Search Results - "Goedegebuure, Ruben S.A."

Hysteroscopic Sterilization Using a Virtual Reality Simulator: Assessment of Learning Curve by Janse, Juliënne A., MD, Goedegebuure, Ruben S.A., MD, Veersema, Sebastiaan, MD, Broekmans, Frank J.M., MD, PhD, Schreuder, Henk W.R., MD, PhD

“…Abstract Study Objective To assess the learning curve using a virtual reality simulator for hysteroscopic sterilization with the Essure method. Design…”
Get full text

Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer? by Goedegebuure, Ruben S A, de Klerk, Leonie K, Bass, Adam J, Derks, Sarah, Thijssen, Victor L J L

“…Radiotherapy has been used for the treatment of cancer for over a century. Throughout this period, the therapeutic benefit of radiotherapy has continuously…”
Get full text

Combining Radiation Therapy With Interferons: Back to the Future by Goedegebuure, Ruben S.A., Vonk, Christian, Kooij, Laura P., Derks, Sarah, Thijssen, Victor L.J.L.

“…Radiation therapy has been linked to the induction of an intratumoral type I interferon (IFN) response, which positively affects the response to treatment…”
Get full text

A Phase I Open-Label Clinical Trial Evaluating the Therapeutic Vaccine [hVEGF.sub.26-104]/RFASE in Patients with Advanced Solid Malignancies by Goedegebuure, Ruben S.A, Wentink, Madelon Q, van der Vliet, Hans J, Timmerman, Peter, Griffioen, Arjan W, de Gruijl, Tanja D, Verheul, Henk M.W

“…Background. Targeting vascular endothelial growth factor-A (VEGF) is a well-established anticancer therapy. We designed a first-in-human clinical trial to…”
Get full text

Development of transient radioresistance during fractionated irradiation in vitro by van den Berg, Jaap, Castricum, Kitty C.M., Meel, Michaël H., Goedegebuure, Ruben S.A., Lagerwaard, Frank J., Slotman, Ben J., Hulleman, Esther, Thijssen, Victor L.J.L.

“…•Multiple colon and brain cancer cell lines were subjected to fractionated irradiation in vitro.•Fractionated irradiation induces transient radioresistance…”
Get full text

A Phase I Open‐Label Clinical Trial Evaluating the Therapeutic Vaccine hVEGF26–104/RFASE in Patients with Advanced Solid Malignancies by Goedegebuure, Ruben S.A., Wentink, Madelon Q., Vliet, Hans J., Timmerman, Peter, Griffioen, Arjan W., Gruijl, Tanja D., Verheul, Henk M.W.

“…Lessons Learned The novel therapeutic vaccine hVEGF26–104/RFASE was found to be safe and well tolerated in patients with cancer. hVEGF26–104/RFASE failed to…”
Get full text

Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation by Goedegebuure, Ruben S A, Kleibeuker, Esther A, Buffa, Francesca M, Castricum, Kitty C M, Haider, Syed, Schulkens, Iris A, Ten Kroode, Luuk, van den Berg, Jaap, Jacobs, Maarten A J M, van Berkel, Anne-Marie, van Grieken, Nicole C T, Derks, Sarah, Slotman, Ben J, Verheul, Henk M W, Harris, Adrian L, Thijssen, Victor L

“…Improvement of radiotherapy efficacy requires better insight in the dynamic responses that occur during irradiation. Here, we aimed to identify the molecular…”
Get full text

Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations by Groen-van Schooten, Tessa S, Harrasser, Micaela, Seidel, Jens, Bos, Emma N, Fleitas, Tania, van Mourik, Monique, Pouw, Roos E, Goedegebuure, Ruben S A, Doeve, Benthe H, Sanders, Jasper, Bos, Joris, van Berge Henegouwen, Mark I, Thijssen, Victor L J L, van Grieken, Nicole C T, van Laarhoven, Hanneke W M, de Gruijl, Tanja D, Derks, Sarah

“…Tumors in the distal esophagus (EAC), gastro-esophageal junction including cardia (GEJAC), and stomach (GAC) develop in close proximity and show strong…”
Get full text